Glial-mediated neuroprotection: Evidence for the protective role of the NO-cGMP pathway via neuron-glial communication in the peripheral nervous system

GLIA

Volumn 49, Issue 2, 2005, Pages 197-210

  Thippeswamy, Thimmasettappa ^a   McKay, Jennifer S ^b   Morris, Richard ^a   Quinn, John ^a   Wong, Liang Fong ^c   Murphy, David ^c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adenoviral vectors; Apoptosis; Dorsal root ganglion neurons; Neurotrophins; Schwann cells

Indexed keywords

ADENOVIRUS VECTOR; CYCLIC GMP; GUANYLATE CYCLASE; NEUROTROPHIN; NITRIC OXIDE; NITRIC OXIDE DONOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; GLIA; GLIA CELL; NERVE CELL; NEUROPROTECTION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; SCHWANN CELL; TRANSGENE;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CYCLIC GMP; CYTOPROTECTION; GANGLIA, SPINAL; GUANYLATE CYCLASE; NERVE DEGENERATION; NEUROGLIA; NEURONS; NEURONS, AFFERENT; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE DONORS; PERIPHERAL NERVOUS SYSTEM; RATS; RATS, WISTAR; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SCHWANN CELLS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 13244298204     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20105     Document Type: Article

References (79)

1. Andoh T, Lee SY, Chiueh CC. 2000. Preconditioning regulation of bcl-2 and p66shc by human NOS1 enhances tolerance to oxidative stress. FASEB J 14:2144-2146.
2. Andoh T, Chock PB, Chiueh CC. 2002. Preconditioning-mediated neuroprotection: role of nitric oxide, cGMP, and new protein expression. Ann NY Acad Sci 962:1-7.
3. Antanitus DS, Choi BH, Lapham LW. 1976. The demonstration of glial fibrillary acidic protein in the cerebrum of the human fetus by indirect immunofluorescence. Brain Res 103:613-616.
4. Arundine M, Tymianski M. 2003. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34:325-337.
5. Bellamy TC, Garthwaite J. 2002. The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells. Mol Cell Biochem 230:165-176.
6. Bonthius DJ, Karacay B, Dai D, Pantazis NJ. 2003. FGF-2, NGF and IGF-1, but not BDNF, utilize a nitric oxide pathway to signal neurotrophic and neuroprotective effects against alcohol toxicity in cerebellar granule cell cultures. Brain Res Dev Brain Res 140:15-28.
7. Chabrier PE, Demerle-Pallardy C, Auguet M. 1999. Nitric oxide synthases: targets for therapeutic strategies in neurological diseases. Cell Mol Life Sci 55:1029-1035.
8. Chao MV. 2003. Retrograde transport redux. Neuron 39:1-2.
9. Cheng L, Esch FS, Marchionni MA, Mudge AW. 1998. Control of Schwann cell survival and proliferation: autocrine factors and neuregulins. Mol Cell Neurosci 12:141-156.
10. Ciani E, Guidi S, Della Valle G, Perini G, Bartesaghi R, Contestable A. 2002a. Nitric oxide protects neuroblastoma cells from apoptosis induced by serum deprivation through cAMP-response element-binding protein (CREB) activation. J Biol Chem 277:49896-49902.
11. Ciani E, Guidi S, Bartesaghi R, Contestabile A. 2002b. Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide. J Neurochem 82:1282-1289.
12. Conover JC, Yancopoulos GD. 1997. Neurotrophin regulation of the developing nervous system: analyses of knockout mice. Rev Neurosci 8:13-27.
13. Delcroix JD, Valletta JS, Wu C, Hunt SJ, Kowal AS, Mobley WC. 2003. NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron 39:69-84.
14. Dhaunsi GS, Ozand PT. 2004. Nitric oxide promotes mitogen-induced DNA synthesis in human dermal fibroblasts through cGMP. Clin Exp Pharmacol Physiol 31:46-49.
15. Diodati JG, Quyyumi AA, Hussain N, Keefer LK. 1993. Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: antiplatelet effect. Thromb Haemost 70:654-658.
16. Djouhri L, Dawbarn D, Robertson A, Newton R, Lawson SN. 2001. Time course and nerve growth factor dependence of inflammation-induced alterations in electrophysiological membrane properties in nociceptive primary afferent neurons. J Neurosci 21:8722-8733.
17. Duchen MR. 2004. Roles of mitochondria in health and disease. Diabetes 53:896-102.
18. Eriksson NP, Lindsay RM, Aldskogius H. 1994. BDNF and NT-3 rescue sensory but not motoneurones following axotomy in the neonate. NeuroReport 5:1445-1448.
19. Estevez AG, Kamaid A, Thompson JA, Cornwell TL, Radi R, Barbeito L, Beckman JS. 2002. Cyclic guanosine 5′ monophosphate (GMP) prevents expression of neuronal nitric oxide synthase and apoptosis in motor neurons deprived of trophic factors in rats. Neurosci Lett 326:201-205.
20. Fiscus RR. 2002. Involvement of Cyclic GMP and Protein Kinase G in the Regulation of Apoptosis and Survival in Neural Cells. Neurosignals 11:175-190.
21. Friedel RH, Schnuren H, Stubbusch J, Barde YA. 1997. Identification of genes differentially expressed by nerve growth factor- and neurotrophin-3- dependent sensory neurons. Proc Natl Acad Sci 94:12670-12675.
22. Gibb BJ, Wykes V, Garthwaite J. 2003. Properties of NO-activated guanylyl cyclases expressed in cells. Br J Pharmacol 139:1032-1040.
23. Griffiths C, Wykes V, Bellamy TC, Garthwaite J. 2003. A new and simple method for delivering clamped nitric oxide concentrations in the physiological range: application to activation of guanylyl cyclase-coupled nitric oxide receptors. Mol Pharmacol 64:1349-1356.
24. Groves MJ, Christopherson T, Giometto B, Scaravilli F. 1999. Axotomy-induced apoptosis in adult rat primary sensory neurons. J Neurocytol 26:615-624.
25. Ha KS, Kim KM, Kwon YG, Bai SK, Nam WD, Yoo YM, Kim PK, Chung HT, Billiar TR, Kim YM. 2003. Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation. FASEB J 17:1036-1047.
26. Harding TC, Geddes BJ, Noel JD, Murphy D, Uney J. 1997. Tetracycline -regulated transgene expression in hippocampal neurons following transfection with adenoviral vectors. J Neurochem 69:2620-2623.
27. Harding TC, Geddes BJ, Murphy D, Knight D, Uney J. 1998. Switching of transgene expression in the brain following transfection by an adenoviral tetracycline-regulatable system. Nature Biotech 16:553-555.
28. Hendriks WT, Ruitenberg MJ, Blits B, Boer GJ, Verhaagen J. 2004. Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. Prog Brain Res 146:451-476.
29. Herzberg U, Eliav E, Dorsey JM, Gracely RH., Kopin IJ. 1997. NGF involvement in pain induced by chronic constriction injury of the rat sciatic nerve. NeuroReport 8:1613-1618.
30. Hory-Lee F, Russell M, Lindsay RM, Frank E. 1993. Neurotrophin 3 supports the survival of developing muscle sensory neurons in culture. Proc Natl Acad Sci USA 90:2613-2617.
31. Kalisch BE, Bock NA, Davis WL, Rylett RJ. 2002. Inhibitors of nitric oxide synthase attenuate nerve growth factor-mediated increases in choline acetyltransferase expression in PC12 cells. J Neurochem 81:624-535.
32. Karchewski LA, Gratto KA, Wetmore C, Verge VM. 2002. Dynamic patterns of BDNF expression in injured sensory neurons: differential modulation by NGF and NT-3. Eur J Neurosci 16:1449-1462.
33. Kashiba H, Uchida Y, Senba E. 2003. Distribution and colocalization of NGF and GDNF family ligand receptor mRNAs in dorsal root and nodose ganglion neurons of adult rats. Brain Res Mol Brain Res 110:52-62.
34. Keefer LK. 2003. Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates. Annu Rev Pharmacol Toxicol 43:585-607.
35. Keilhoff G, Fansa H, Wolf G. 2002. Neuronal nitric oxide synthase is the dominant nitric oxide supplier for the survival of dorsal root ganglia after peripheral nerve axotomy. J Chem Neuroanat 24:181-187.
36. -. Neuron 24:461-469.
37. Koesling D, Friebe A. 2000. Enzymology of soluble guanylyl cyclase. In: Mayer B, editor. Nitric oxide. Berlin: Springer, p 93-109.
38. Koschorreck S, Wenzel F, Fuhrmann M, Racke K. 2003. Effects of phosphodiesterase inhibitors on L-arginine pathways in rat alveolar macrophages. Eur J Pharmacol 471:229-236.
39. Kowaluk EA, Seth P, Fung HL. 1992. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther 262:916-922.
40. Lam CF, Sviri S, Ilett KF, van Heerden PV. 2002. Inhaled diazeniumdiolates (NONOates) as selective pulmonary vasodilators. Expert Opin Invest Drugs 11:897-909.
41. Lawrence JM, Keegan DJ, Muir EM, Coffey PJ, Rogers JH, Wilby MJ, Fawcett JW, Lund RD. 2004. Transplantation of Schwann cell line clones secreting GDNF or BDNF into the retinas of dystrophic Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 45:267-274.
42. Lindsay RM, Wiegand SJ, Altar CA, Di Stefano PS. 1994. Neurotrophic factors: from molecule to man. Trends Neurosci 17:182-190.
43. Lipton SA. 1999. Neuronal protection and destruction by NO. Cell Death Differ 10:943-951.
44. Lipton SA, Singel DJ, Stamler JS. 1994. Nitric oxide in the central nervous system. Prog Brain Res 103:359-364.
45. Liu H, Force T, Bloch KD. 1997. Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma (PC12) cells. J Biol Chem 272:6038-6043.
46. Manni L, Lundeberg T, Fiorito S, Bonini S, Vigneti E, Aloe L. 2003. Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response. Clin Exp Rheumatol 21:617-624.
47. Morley D, Keefer LK. 1993. Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J Cardiovasc Pharmacol 22:S3-S9.
48. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
49. Mizusawa I, Abe S, Kanno K, Yabashi A, Honda T, Suto M, Hiraiwa K. 2003. Expression of cytokines, neurotrophins, neurotrophin receptors and NOS mRNA in dorsal root ganglion of a rat tourniquet model. Leg Med 5:8271-274.
50. Morgan DL, Shines CJ. 2004. Alveolar macrophage cytotoxicity for normal lung fibroblasts is mediated by nitric oxide release. Toxicol In Vitro 18:139-146.
51. Nakamizo T, Kawamata J, Yoshida K, Kawai Y, Kanki R, Sawada H, Kihara T, Yamashita H, Shibasaki H, Akaike A, Shimohama S. 2003. Phosphodiesterase inhibitors are neuroprotective to cultured spinal motor neurons. J Neurosci Res 71:485-495.
52. Nalwaya N, Deen WM. 2004. Analysis of the effects of nitric oxide and oxygen on nitric oxide production by macrophages. J Theor Biol 226:409-419.
53. Nelson EJ, Connolly J, McArthur P. 2003. Nitric oxide and S-nitrosylation: excitotoxic and cell signaling mechanism. Biol Cell 95:3-8.
54. Niwa H, Hayakawa K, Yamamoto M, Itoh T, Mitsuma T, Sobue GD. 2002. Differential age-dependent trophic responses of nodose, sensory, and sympathetic neurons to neurotrophins and GDNF: potencies for neurite extension in expiant culture. Neurochem Res 27:485-496.
55. Oakley RA, Garner AS, Large TH, Frank E. 1995. Muscle sensory neurons require neurotrophin-3 from peripheral tissues during the period of normal cell death. Development 121:1341-1350.
56. Oliveira AL, Risling M, Negro A, Langone F, Cullheim S. 2002. Apoptosis of spinal interneurons induced by sciatic nerve axotomy in the neonatal rat is counteracted by nerve growth factor and ciliary neurotrophic factor. J Comp Neurol 447:381-393.
57. Park SY, Choi JY, Kim RU, Lee YS, Cho HJ, Kim DS. 2003. Downregulation of voltage-gated potassium channel alpha gene expression by axotomy and neurotrophins in rat dorsal root ganglia. Mol Cells 16:256-259.
58. Schmidt HHHW, Warner TD, Nakane M, Foerstermann U, Murad F. 1992. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol Pharmacol 41:615-624.
59. Sebert ME, Shooter EM. 1993. Expression of mRNA for neurotrophic factors and their receptors in the rat dorsal root ganglion and sciatic nerve following nerve injury. J Neurosci Res 36:357-367.
60. Shi TJ, Holmberg K, Xu ZQ, Steinbusch H, de Vente J, Hokfelt T. 1998. Effect of peripheral nerve injury on cGMP and NOS levels in rat DRG: time course and coexistence. Pain 78:171-180.
61. Snyder SH, Kim S. 2004. No glial death with NO. Nat Cell Biol 6:17-18.
62. Takuma K, Phuagphong P, Lee E, Mori K, Baba A, Matsuda T. 2001. Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J Biol Chem 276:48093-48099.
63. Thippeswamy T, Morris R. 1997a. Cyclic guanosine 3′,5′- monophosphate (cGMP) mediated neuroprotection by nitric oxide in dissociated cultures of rat dorsal root ganglion neurons. Brain Res 774:116-122.
64. Thippeswamy T, Morris R. 1997b. Nerve growth factor inhibits expression of neuronal nitric oxide synthase in dissociated cultures of dorsal root ganglia. Neurosci Lett 230:9-12.
65. Thippeswamy T, Morris K. 2001a. Evidence that nitric oxide induced synthesis of cGMP occurs in a paracrine but not autocrine fashion and that the site of its release can be regulated: studies in dorsal root ganglia in vivo and in vitro. Nitric Oxide Biol Chem 5:105-115.
66. Thippeswamy T, Morris R. 2001b. Nitric Oxide versus nerve growth factor: who matters and when? Studies from dorsal root ganglia. Curr Opin Clin Exp Res 3:196-216.
67. Thippeswamy T, McKay J S, Morris R. 2001a. Bax and caspases are inhibited by endogenous nitric oxide in dorsal root ganglion neurons in vitro. Eur J Neurosci 40:1229-1236.
68. Thippeswamy T, Jain RK, Mumtaz N, Morris R. 2001b. Inhibition of neuronal nitric oxide synthase results in neurodegenerative changes in the axotomised dorsal root ganglion neurons: evidence for a neuroprotective role of nitric oxide in vivo. Neurosci Res 40:37-44.
69. Thippeswamy T, McKay JS, Morris R. 2002a. cGMP is required for the survival of satellite glia cells in axotomised DRG. Glia 38(S36):110.
70. Thippeswamy T, McKay JS, Quinn J. 2002b. NO-cGMP pathway induces nerve growth factor in peripheral glia cells. 3rd Forum of Eur Neurosci Abs 3:151.
71. Weill CL, Greene DP. 1984. Prevention of natural motoneurone cell death by dibutyryl cyclic GMP. Nature 308:482-482.
72. Wirtz-Brugger F, Giovanni A. 2000. Guanosine 3′,5′-cyclic monophosphate mediated inhibition of cell death induced by nerve growth factor withdrawal and beta-amyloid: protective effects of propentofylline. Neuroscience 99:737-750.
73. Wong L-F, Murphy D. 2002. Adenoviral-mediated over-expression of Brn2 in the rat paraventricular nucleus: no effect on vasopressin or corticotrophin releasing factor RNA levels. Mol Cell Endocrinol 200:165-175.
74. Wong L-F, Harding T, Uney J, Murphy D. 2003. cAMP-dependent protein A (PKA) mediation of vasopressin expression in the hypothalamus of the osmotically challenge rat. Mol Cell Neurosci 24:82-89.
75. Wykes V, Bellamy TC, Garthwaite J. 2002. Kinetics of nitric oxide-cyclic GMP signalling in CNS cells and its possible regulation by cyclic GMP. J Neurochem 83:37-47.
76. Wu, A, Li L, Liu Y. 2003. Deltamethrin induces apoptotic cell death in cultured cerebral cortical neurons. Toxicol Appl Pharmacol 187:50-57.
77. Yuen PST, Doolittle LK, Garbers DL. 1994. Dominant negative mutants of nitric oxide-sensitive guanylyl cyclase. J Biol Chem 269:791-793.
78. Zhang X, Verge V, Wiesenfeld HZ, Ju G, Bredt D, Synder SH, Hokfelt T. 1993. NOS-like immunoreactivity in lumbar DRG and spinal cord of rat and monkey and effect of peripheral axotomy. J Comp Neurol 335:563-575.
79. Zhou XF, Deng YS, Chie E, Xue Q, Zhong JH, McLachlan EM, Rush RA, Xian CJ. 1999. Satellite-cell-derived nerve growth factor and neurotrophin-3 are involved in noradrenergic sprouting in the dorsal root ganglia following peripheral nerve injury in the rat. Eur J Neurosci 11:1711-1722.